Applied Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Applied Therapeutics

05/05/2025 14:31

Applied Therapeutics Inc APLT.OQ APLT.O is expected to show a rise in quarterly revenue when it reports  results on May 7 (estimated) for the period ending March 31 2025

The New York City-based  company is expected to report a 2,312.3% increase in revenue to $4.583 million from $190 thousand a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Applied Therapeutics Inc is for a loss of 19 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts had risen by about 9.1% in the last three months. ​

Wall Street's median 12-month price target for Applied Therapeutics Inc is $2.50​, above​ its last closing price of $0.46. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.18
0.33
Beat
285.9
Sep. 30 2024
-0.16
-0.16
-0.48
Missed
-203.8
Jun. 30 2024
-0.15
-0.16
0.02
Beat
112.2​
Mar. 31 2024
-0.16
-0.16
-0.67
Missed
-320.1
​​Dec. 31 2023
-0.20
-0.23
-0.34
Missed
-49.1
Sep. 30 2023
-0.23
-0.26
-0.47
Missed
-81.2​
Jun. 30 2023
-0.17
-0.26
-0.37
Missed
-39.6
Mar. 31 2023
-0.27
-0.31
-0.18
Beat
41.3

This summary was machine generated May 5 at 13:31 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)